Related Experiment Video
Updated: Jun 19, 2026

A New Method for Qualitative Multi-scale Analysis of Bacterial Biofilms on Filamentous Fungal Colonies Using Confocal and Electron Microscopy
Published on: January 25, 2017
Our current understanding of fungal biofilms
Gordon Ramage1, Eilidh Mowat, Brian Jones
1Section of Infection and Immunity, Glasgow Dental School and Hospital, Faculty of Medicine, University of Glasgow, UK. g.ramage@dental.gla.ac.uk
Abstract:
Fungal biofilms are an escalating clinical problem associated with significant rates of mortality. Candida albicans is the most notorious of all fungal biofilm formers. However, non-Candida species, yeasts such as Cryptococcus neoformans, and filamentous moulds such as Aspergillus fumigatus, have been shown to be implicated in biofilm-associated infections. Fungal biofilms have distinct developmental phases, including adhesion, colonisation, maturation and dispersal, which are governed by complex molecular events. Recalcitrance to antifungal therapy remains the greatest threat to patients with fungal biofilms. This review discusses our current understanding of the basic biology and clinical implications associated with fungal biofilms.
Insights
Fungal biofilms pose a growing threat, causing high mortality rates. This review explores the biology and clinical impact of fungal biofilms, highlighting their resistance to antifungal treatments.
Area of Science:
- Mycology
- Infectious Diseases
- Biotechnology
Background:
- Fungal biofilms are a significant clinical challenge, linked to substantial mortality.
- Candida albicans is a primary cause, but other fungi like Cryptococcus neoformans and Aspergillus fumigatus also form biofilms.
- These biofilms exhibit distinct developmental stages: adhesion, colonization, maturation, and dispersal, regulated by intricate molecular pathways.
Purpose of the Study:
- To review the current understanding of fungal biofilm biology.
- To discuss the clinical implications of fungal biofilm infections.
- To highlight the challenge of antifungal recalcitrance in biofilm-associated diseases.
Main Methods:
- Literature review of basic fungal biofilm biology.
- Analysis of clinical data related to fungal biofilm infections.
- Synthesis of information on molecular mechanisms governing biofilm development.
Main Results:
- Fungal biofilms present a major clinical threat with high mortality rates.
- Multiple fungal species, beyond Candida albicans, are implicated in biofilm infections.
- Antifungal recalcitrance is a critical challenge in treating fungal biofilm infections.
Conclusions:
- A comprehensive understanding of fungal biofilm biology is crucial for developing effective treatments.
- Addressing the inherent resistance of fungal biofilms to antifungal therapies is paramount.
- Further research into the molecular underpinnings of fungal biofilms is needed to combat associated infections.
Related Concept Videos
Biofilms
Overview of Fungi
Fungal Group Zygomycota
Biodeterioration
Antifungal Agents

